These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 19198701

  • 1. Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.
    Thadani U, Jacob RG.
    Drugs Today (Barc); 2008 Dec; 44(12):925-37. PubMed ID: 19198701
    [Abstract] [Full Text] [Related]

  • 2. A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination.
    Cheng JW.
    Clin Ther; 2006 May; 28(5):666-78. PubMed ID: 16861089
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
    Hammermeister KE, Fairclough D, Emsermann CB, Hamman R, Ho M, Phibbs S, Plomondon M, Valuck R, West D, Steiner JF.
    Clin Ther; 2009 Mar; 31(3):632-43. PubMed ID: 19393854
    [Abstract] [Full Text] [Related]

  • 5. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
    Golwala HB, Thadani U, Liang L, Stavrakis S, Butler J, Yancy CW, Bhatt DL, Hernandez AF, Fonarow GC.
    J Am Heart Assoc; 2013 Aug 21; 2(4):e000214. PubMed ID: 23966379
    [Abstract] [Full Text] [Related]

  • 6. Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: the V-HeFT paradox.
    Tam SW, Sabolinski ML, Worcel M, Packer M, Cohn JN.
    Clin Pharmacokinet; 2007 Aug 21; 46(10):885-95. PubMed ID: 17854237
    [Abstract] [Full Text] [Related]

  • 7. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT).
    Carson P, Johnson G, Fletcher R, Cohn J.
    J Am Coll Cardiol; 1996 Mar 01; 27(3):642-9. PubMed ID: 8606276
    [Abstract] [Full Text] [Related]

  • 8. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
    Loeb HS, Johnson G, Henrick A, Smith R, Wilson J, Cremo R, Cohn JN.
    Circulation; 1993 Jun 01; 87(6 Suppl):VI78-87. PubMed ID: 8500244
    [Abstract] [Full Text] [Related]

  • 9. Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial.
    Ferdinand KC, Elkayam U, Mancini D, Ofili E, Piña I, Anand I, Feldman AM, McNamara D, Leggett C.
    Am J Cardiol; 2014 Jul 01; 114(1):151-9. PubMed ID: 24846808
    [Abstract] [Full Text] [Related]

  • 10. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Ziesche S, Cobb FR, Cohn JN, Johnson G, Tristani F.
    Circulation; 1993 Jun 01; 87(6 Suppl):VI56-64. PubMed ID: 8500241
    [Abstract] [Full Text] [Related]

  • 11. Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.
    Elkayam U, Bitar F.
    Am J Cardiol; 2005 Oct 10; 96(7B):37i-43i. PubMed ID: 16226934
    [Abstract] [Full Text] [Related]

  • 12. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC, Chakraborty S, Mondal M, Bhandari B.
    J Assoc Physicians India; 1993 May 10; 41(5):269-71. PubMed ID: 8300456
    [Abstract] [Full Text] [Related]

  • 13. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry.
    Khazanie P, Liang L, Curtis LH, Butler J, Eapen ZJ, Heidenreich PA, Bhatt DL, Peterson ED, Yancy CW, Fonarow GC, Hernandez AF.
    Circ Heart Fail; 2016 Feb 10; 9(2):e002444. PubMed ID: 26867758
    [Abstract] [Full Text] [Related]

  • 14. The impact of race on response to RAAS inhibition.
    Wallace TW, Drazner MH.
    Curr Heart Fail Rep; 2005 Aug 10; 2(2):72-7. PubMed ID: 16036054
    [Abstract] [Full Text] [Related]

  • 15. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A.
    Circulation; 1993 Jun 10; 87(6 Suppl):VI40-8. PubMed ID: 8500238
    [Abstract] [Full Text] [Related]

  • 16. Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction.
    Nyolczas N, Dékány M, Muk B, Szabó B.
    Adv Exp Med Biol; 2018 Jun 10; 1067():31-45. PubMed ID: 29086392
    [Abstract] [Full Text] [Related]

  • 17. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
    Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN, A-HeFT Investigators.
    Am J Cardiovasc Drugs; 2007 Jun 10; 7(5):373-80. PubMed ID: 18041162
    [Abstract] [Full Text] [Related]

  • 18. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
    Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN, African-American Heart Failure Trial Investigators.
    N Engl J Med; 2004 Nov 11; 351(20):2049-57. PubMed ID: 15533851
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure.
    Angus DC, Linde-Zwirble WT, Tam SW, Ghali JK, Sabolinski ML, Villagra VG, Winkelmayer WC, Worcel M, African-American Heart Failure Trial (A-HeFT) Investigators.
    Circulation; 2005 Dec 13; 112(24):3745-53. PubMed ID: 16344404
    [Abstract] [Full Text] [Related]

  • 20. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure.
    Ziaeian B, Fonarow GC, Heidenreich PA.
    JACC Heart Fail; 2017 Sep 13; 5(9):632-639. PubMed ID: 28711446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.